Alpine Immune Sciences to Participate in the Evercore ISI HealthconX Conference
Washingtoner/10239592

SEATTLE ~ Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a clinical-stage immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases, will be participating in the upcoming Evercore ISI HealthconX Conference from November 28th to 30th. On Thursday, November 30th, the Company will host a fireside chat at 7:55 am ET/4:55 am PT and investor meetings. A live webcast of the fireside chat will be available on the Company's website and a replay will be available for 90 days following the event.

More on Washingtoner

• K2 Integrity Names Michael Kallabat Global Head of Investigations and Disputes
• Socialhose Eyes Southeast Asia and Rejects the Copy-Paste Expansion Playbook
• $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
• Tacoma City Council Expresses Opposition to Initiative Measure No. IL26-001 and Initiative Measure No. IL26-638
• As the FCC Router Ban Creates a National Supply Chain Crisis, Haawke Hash Offers the Infrastructure

---

Show All News | Disclaimer | Report Violation